336
Views
0
CrossRef citations to date
0
Altmetric
Review

Vitamin D status and its management for achieving optimal health benefits in the elderly

ORCID Icon
Pages 279-293 | Received 08 Jun 2018, Accepted 04 Oct 2018, Published online: 14 Oct 2018

References

  • MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76:1536–1538.
  • Rowe M, Timms PM, Boucher BJ, et al. Comment on Chocolate consumption and cardiometabolicdisorders: systematic review and meta-analysis. BMJ. 2011 Dec 1;95:d4488.
  • Jääskeläinen T, Itkonen ST, Lundqvist A, et al. The positive impact of general vitaminD food fortification policy on vitamin D status in a representative adult Finnish population: evidence from an 11-y follow-up based on standardized 25-hydroxyvitamin D data. Am J Clin Nutr. 2017;105:1512–1520.
  • Wyskida M, Wieczorowska-Tobis K, Chudek J. Prevalence and factors promoting the occurrence of vitamin D deficiency in the elderly. Postepy Hig Med Dosw. 2017;71:198–204. Review.
  • Barragry J, France MW, Corless D, et al. Intestinal choleclaiferol absorption in teh elderly and in younger adults. Clin Sci Mol Med. 1978;55:213–220.
  • Bischoff-Ferrari HA, Borchers M, Gudat F, et al. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004;19:265–269.
  • Boucher BJ. Calcium supplements may increase the risk of cardiovascular events in postmenopausal women. Evid Based Med. 2012;17:16–17.
  • Berridge MJ. Vitamin D deficiency accelerates ageing and age-related diseases: a novel hypothesis. J Physiol. 2017;595:6825–6836.
  • Adams JS, Rafison B, Witzel S, et al. Regulation of the extrarenal CYP27B1-hydroxylase. J Steroid Biochem Mol Biol. 2014;144(Pt A):22–27.
  • Slominski AT, Kim TK, Takeda Y, et al. RORa and RORy are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy and 20,23-dihydroxyvitamin D. FASEB J. 2014;28:2775–2789.
  • Slominski AT, Kim TK, Shehabi HZ, et al. In vivo evidence for a novel pathway of vitamin D₃ metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 2012;26:3901–3915.
  • Kaseda R, Hosojima M, Sato H, et al. Role of megalin and cubilin in the metabolism of vitamin D(3). Ther Apher Dial. 2011;15(Suppl 1):14–17.
  • Carlberg C, Molnár F. Vitamin D receptor signaling and its therapeutic implications: genome-wide and structural view. Can J Physiol Pharmacol. 2015;93:311–318.
  • Norman AW. Mini-review: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147:5542–5548.
  • Berti C, Agostoni C, Davanzo R, et al. Early-life nutritional exposures and lifelong health: immediate and long-lasting impacts of probiotics, vitamin D, and breastfeeding. Nutr Rev. 2017;75:83–97.
  • Holroyd C, Harvey N, Dennison E, et al. Epigenetic influences in the developmental origins of osteoporosis. Osteoporos Int. 2012;23:401–410.
  • Godfrey KM, Costello PM, Lillycrop KA. Development, epigenetics and metabolic programming. Nestle Nutr Inst Workshop Ser. 2016;85:71–80.
  • Kinyamu HK1, Gallagher JC, Petranick KM, et al. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women. J Bone Miner Res. 1996;11:1400–1405.
  • Gladych M, Wojtyla A, Rubis B. Human telomerase expression regulation. Biochem Cell Biol. 2011;89:359–376. Review.
  • Yeh JK, Wang CY. Telomeres and telomerase in cardiovascular diseases. Genes. 2016;7(9):pii:E58.
  • Pusceddu I, Herrmann M, Kirsch SH, et al. One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation. Eur J Nutr. 2017;56:1887–1898.
  • Siebert C, Dos Santos TM, Bertó CG. Vitamin D supplementation reverses DNA damage and telomeres shortening caused by ovariectomy in hippocampus of Wistar rats. Neurotox Res. 2018;34:538–546.
  • Høyer-Hansen M, Nordbrandt SP, Jäättelä M. Autophagy as a basis for the health-promoting effects of vitamin D. Trends Mol Med. 2010;16:295–302.
  • Dudenkov DV, Mara KC, Petterson TM, et al. Serum 25-Hydroxyvitamin D values and risk of all-cause and cause-specific mortality: a population-based cohort study. Mayo Clin Proc. 2018;93:721–730.
  • Zhu K, Knuiman M, Divitini M, et al. Serum 25-hydroxyvitamin D as a predictor of mortality and cardiovascular events: a 20-year study of a community-based cohort. Clin Endocrinol. 2018;88:154–163.
  • Majeed Babar MZ, Haider SS, Mustafa G. Effects of Vitamin D supplementation on physical activity of patients with heart failure. Pak J Med Sci. 2016;32:1430–1433.
  • Brenner H, Jansen KU, Saum KU, et al. Supplementation trials aimed at reducing mortality have much higher power when focussing on people with low serum 24-hydroxyvitamin D levels. B J Nutr. 2017;147:1325–1333.
  • Rejnmark L, Bislev LS, Cashman KD, et al. Non-skeletal health effects of vitamin D supplementation: a systematic review on findings from meta-analyses summarizing trial data. PLoS One. 2017;12:e0180512.
  • Merke J, Milde P, Lewicka S, et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest. 1989;83:1903–1915.
  • Polly P, Tan TC. The role of vitamin D in skeletal and cardiac muscle function. Front Physiol. 2014;5:145.
  • Tamayo M, Manzanares E, Bas M, et al. Calcitriol (1,25-dihydroxyvitamin D3) increases L-type calcium current via protein kinase A signaling and modulates calcium cycling and contractility in isolated mouse ventricular myocytes. Heart Rhythm. 2017;14:432–439.
  • Verdoia M, Schaffer A, Sartori C, et al. Vitamin D deficiency is independently associated with the extent of coronary artery disease. Eur J Clin Invest. 2014;44:634–642.
  • Zhong Y, Lu YT, Shi ZH, et al. Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer. Expert Opin Drug Discov. 2018;13:75–87.
  • Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? Qjm. 2002;95:787–796.
  • Calton EK, Keane KN, Newsholme P, et al. The impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials. Eur J Clin Nutr. 2017;71:931–943.
  • Srikanth P, Chun RF, Hewison M, et al. Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men. Osteoporotic fractures in men (MrOS) study research group. Osteoporos Int. 2016;27:2291–2300.
  • Bivona G, Agnello L, Ciaccio M. Vitamin D and Immunomodulation: is It Time to Change the Reference Values? Ann Clin Lab Sci. 2017;47:508–510.
  • Michos ED, Selvin E, Misialek JR, et al. 25-Hydroxyvitamin D levels and markers of subclinical myocardial damage and wall stress: the atherosclerosis risk in communities study. J Am Heart Assoc. 2016;5:pii: e003575.
  • Chang WT, Wu CH, Hsu LW, et al. Serum vitamin D, intact parathyroid hormone, and Fetuin A concentrations were associated with geriatric sarcopenia and cardiac hypertrophy. Sci Rep. 2017;7:40996.
  • Mozos I, Stoian D, Luca CT. Crosstalk between Vitamins A, B12, D, K, C, and E status and arterial stiffness. Dis Markers. 2017;2017:8784971.
  • Faridi KF, Lupton JR, Martin SS, et al. Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk. Arch Med Sci. 2017;13:732–737.
  • Alonso A, Artemis D, Hennerici MG. Molecular imaging of carotid plaque vulnerability. Cerebrovasc Dis. 2015;39:5–12.
  • Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607.
  • Reaven G. Syndrome X. Curr Treat Options Cardiovasc Med. 2001;3:323–332.
  • Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’? Br J Nutr. 1998;79:315–327. Review.
  • Grant WB. Benefits of ultraviolet-B irradiance and vitamin D in youth. J Steroid Biochem Mol Biol. 2013;136:221–223.
  • Slominski AT, Zmijewski MA, Plonka PM, et al. How UV light touches the brain and endocrine system through skin, and why. Endocrinology. 2018;159:1992–2007.
  • Dutta D, Maisnam I, Shrivastava A, et al. Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res. 2013;138:853–860.
  • von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomized, placebo-controlled trial. Br J Nutr. 2010;103:549–555.
  • Li X, Liu Y, Zheng Y, et al. The effect of vitamin D supplementation on glycemic control in Type 2 diabetes patients: a systematic review and meta-analysis. Nutrients. 2018;10(3):pii: E375.
  • He S, Yu S, Zhou Z, et al. Effect of vitamin D supplementation on fasting plasma glucose, insulin resistance and prevention of type 2 diabetes mellitus in non-diabetics: a systematic review and meta-analysis. Biomed Rep. 2018;8:475–484.
  • Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10:e1001383.
  • Hyppönen E, Boucher BJ. Adiposity, vitamin D requirements and clinical implications for obesity-related metabolic abnormalities. Nutr Rev. 2018;76:678–692.
  • Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229–238.
  • Chang HR, Tsao DA, Wang SR, et al. Expression of nitric oxide synthases in keratinocytes after UVB irradiation. Arch Dermatol Res. 2003;295:293–296.
  • Juzeniene A, Moan J. Beneficial effects of UV radiation other than via vitamin D production. Dermatoendocrinol. 2012;4:109–117.
  • Forouhi NG, Menon RK, Sharp SJ, et al. Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial. Diabetes Obes Metab. 2016;18:392–400.
  • Beveridge LA, Witham MD. Controversy in the link between vitamin D supplementation and hypertension. Expert Rev Cardiovasc Ther. 2015;13:971–973.
  • Qi D, Nie X, Cai J. The effect of vitamin D supplementation on hypertension in non-CKD populations: a systemic review and meta-analysis. Review Int J Cardiol. 2017;227:177–186.
  • Ji L, Gupta M, Feldman BJ. Vitamin d regulates fatty acid composition in subcutaneous adipose tissue through Elov13. Endocrinol. 2016;157:91–97.
  • Ponda MP, Huang X, Odeh MA, et al. Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation. 2012;126:270–277.
  • Wang H, Xia N, Yang Y, et al. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis. 2012;11:42.
  • Hyppönen E, Boucher BJ. Vitamin D, obesity, and the metabolic syndrome. Chapter 78. In: Feldman D, Wesley-Pike J, Bouillon R, et al. editors. Vitamin D. 4th ed. 2017;2:425–444.
  • Jablonski KL, Jovanovich A, Holmen J, et al. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2013;23:792–798.
  • Targher G, Byrne CD. Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases: is there a causal link? Endocrine. 2014;47:3–4.
  • Wang X, Li W, Zhang Y, et al. Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis. Int J Clin Exp Med. 2015;8:17221–17734.
  • Yin Y, Yu Z, Xia M, et al. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism. Eur J Clin Invest. 2012;42:1189–1196.
  • Cheng Q, Boucher BJ, Leung PS. Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice. Diabetologia. 2013;56:553–562.
  • Saberi B, Dadabhai AS, Nanavati J, et al. Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: a PRISMA compliant systematic review and meta-analysis of pooled data. Hepatol. 2018;10:142–154.
  • Malmström H, Walldius G, Carlsson S, et al. Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: experience from the AMORIS study. Diabetes Obes Metab. 2018;20:1419–1426.
  • Kadowaki S, Norman AW. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest. 1984;73:759–766.
  • Kadowaki S, Norman AW. Demonstration that the vitamin D metabolite 1,25(OH)2-vitamin D3 and not 24R,25(OH)-vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes. 1985;34:315–320.
  • Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909–2912.
  • Martineau AR, Wilkinson KA, Newton SM, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelecidin LL-37. J Immunol. 2007;178:7190–7198.
  • Trochoutsou AI, Kloukina V, Samitas K, et al. Vitamin-D in the Immune System: genomic and Non-Genomic Actions. Mini Rev Med Chem. 2015;15:953–963.
  • Al-Tarrah K, Hewison M, Moiemen N, et al. Vitamin D status and its influence on outcomes following major burn injury and critical illness. Burns Trauma. 2018;6:11.
  • Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA. 2012;109:15449–15454.
  • Ganmaa D, Munkhzul B, Fawzi W, et al. High-dose vitamin D3 during tuberculosis treatment in Mongolia. A randomized controlled trial. Am J Respir Crit Care Med. 2017;196:628–637.
  • Vanoirbeek E, Krishnan A, Eelen G, et al. The anti-cancer and anti-inflammatory actions of 1,25(OH). Best Pract Res Clin Endocrinol Metab. 2011;25:593–604.
  • Sarkar S, Hewison M, Studzinski GP, et al. Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer. Crit Rev Clin Lab Sci. 2016;53:132–145.
  • Yang CY, Leung PS, Adamopoulos IE, et al. The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol. 2013;45:217–226.
  • Altieri B, Muscogiuri G, Barrea L, et al. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord. 2017;18:335–346.
  • Hyppönen E, Läärä E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358(9292):1500–1503.
  • The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia. 1999;42:51–54.
  • Sørensen IM, Joner G, Jenum PA, et al. Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes. 2012;61:175–178.
  • Ball SJ, Haynes A, Jacoby P, et al. Spatial and temporal variation in type 1 diabetes incidence in Western Australia from 1991 to 2010: increased risk at higher latitudes and over time. Health Place. 2014;28:194–204.
  • Griz LH, Bandeira F, Gabbay MA, et al. Vitamin D and diabetes mellitus: an update 2013. Arq Bras Endocrinol Metabol. 2014;58:1–8.
  • Mäkinen M, Simell V, Mykkänen J, et al. An increase in serum 25-hydroxyvitamin D concentrations preceded a plateau in type 1 diabetes incidence in Finnish children. J Clin Endocrinol Metab. 2014;99:E2353–E23536.
  • Bakr HG, Meawed TE. Relevance of 25 (OH) vitamin D deficiency on Hashimoto’s thyroiditis. Egypt J Immunol. 2017;24:53–56.
  • Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease? A systematic review. Semin Arthritis Rheum. 2011;40:512–531.
  • Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010;39:365–379.
  • Mao X, Hu B, Zhou Z, et al. Vitamin D levels correlate with lymphocyte subsets in elderly patients with age-related diseases. Sci Rep. 2018;8:7708.
  • Cui X, Gooch H, Petty A, et al. Vitamin D and the brain: genomic and non-genomic actions. Mol Cell Endocrinol. 2017;453:131–143.
  • Schlögl M, Holick MF. Vitamin D and neurocognitive function. Clin Interv Aging. 2014;9:559–568.
  • Buell JS, Dawson-Hughes B, Scott TM, et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology. 2010;74:18–26.
  • Annweiler C, Dursun E, Féron F, et al. Vitamin D and cognition in older adults: international consensus guidelines. Geriatr Psychol Neuropsychiatr Vieil. 2016;14:265–273.
  • Gold JJ, Shoaib A, Gorthy G, et al. The role of vitamin D in cognitive disorders in older adults. US Neurology. 2018;14:41-46. DOI:10.17925/usn.2018.14.1.41
  • Solfrizzi V, Agosti P, Lozupone M, et al. Nutritional intervention as a preventive approach for cognitive-related outcomes in cognitively healthy older adults: a systematic review. J Alzheimers Dis. 2018. DOI:10.3233/JAD-179940
  • Mokry LE, Ross S, Morris JA, et al. Genetically decreased vitamin D and risk of Alzheimer disease. Neurology. 2016;87(24):2567–2574.
  • Jayedi A, Rashidy-Pour A, Shab-Bidar S. Vitamin D status and risk of dementia and Alzheimer’s disease: a meta-analysis of dose-response. Nutr Neurosci. 2018;15:1–10.
  • Lerner PP, Sharony L, Miodownik C. Association between mental disorders, cognitive disturbances and vitamin D serum level: current state. Clin Nutr ESPEN. 2018;23:89–102.
  • Chao CT, Chiang CK, Huang JW, et al. Vitamin D is closely linked to the clinical courses of herpes zoster: from pathogenesis to complications. Med Hypotheses. 2015;85:452–457.
  • Chao CT, Lee SY, Yang WS, et al. Serum vitamin D levels are positively associated with varicella zoster immunity in chronic dialysis patients. Sci Rep. 2014;4:737.
  • Jorde R, Sollid ST, Svartberg J, et al. Prevention of urinary tract infections with vitamin D supplementation 20,000 IU per week for five years. Results from an RCT including 511 subjects. Infect Dis (Lond). 2016;48:823–828.
  • Oberg J, Verelst M, Jorde R, et al. High dose vitamin D may improve lower urinary tract symptoms in postmenopausal women. J Steroid Biochem Mol Biol. 2017;173:28–32.
  • Grant WB. Vitamin D status: ready for guiding prostate cancer diagnosis and treatment? Clin Cancer Res. 2014;20:2241–2243.
  • Campolina-Silva GH, Maria BT, Mahecha GAB, et al. Reduced vitamin D receptor (VDR) expression and plasma vitamin D levels are associated with aging-related prostate lesions. Prostate. 2018;78:532–546.
  • Campolina-Silva GH, Maria BT, Mahecha GAB, et al. Self-administration of vitamin D supplements in the general public may be associated with high 25-hydroxyvitamin D concentrations. Ann Clin Biochem. 2017;54:355–361.
  • Mak RH. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int. 1992;41:1049–1054.
  • Lin SH, Lin YF, Lu KC, et al. Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uraemic patients with secondary hyperparathyroidism. Clin Sci. 1994;87:533–538.
  • Arora E, Singh H, Gupta YK. Impact of antiepileptic drugs on bone health: need for monitoring, treatment, and prevention strategies. J Family Med Prim Care. 2016;5:248–253. Review.
  • Riche KD, Arnall J, Rieser K, et al. Impact of vitamin D status on statin-induced myopathy. J Clin Transl Endocrinol. 2016;6:56–59.
  • Grimes DS. Are statins analogues of vitamin D? Lancet. 2006;368(9529):83–86.
  • Soodgupta D, Kaul D, Kanwar AJ, et al. Modulation of LXR-α and the effector genes by Ascorbic acid and Statins in psoriatic keratinocytes. Mol Cell Biochem. 2014;397:1–6.
  • Bischoff-Ferrari HA, Fischer K, Orav EJ, et al. Statin use and 25-Hydroxyvitamin D blood level response to vitamin D treatment of older adults. J Am Geriatr Soc. 2017;65:1267–1273.
  • Bergman P, Norlin AC, Hansen S, et al. Vitamin D supplementation improves well-being in patients with frequent respiratory tract infections: a post hoc analysis of a randomized, placebo-controlled trial. BMC Res Notes. 2015;8:498.
  • Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i658.
  • Ginde AA, Blatchford P, Breese K, et al. High-dose monthly vitamin D for prevention of acuterespiratory infection in older long-term care residents: a randomized clinical trial. J Am Geriatr Soc. 2017;65:496–503.
  • Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir Med. 2017;5:881–890.
  • Martineau AR, James WY, Hooper RL, et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomized controlled trial. Lancet Respir Med. 2015;3:120–130.
  • Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586–1591.
  • McDonnell SL, Baggerly C, French CB, et al. Serum 25-Hydroxyvitamin D concentrations ≥40 ng/ml are associated with >65% lower cancer risk: pooled analysis of randomized trial and prospective cohort study. PLoS One. 2016;11:e0152441.
  • Moukayed M, Grant WB. The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: a review of the epidemiology, clinical trials, and mechanisms. Rev Endocr Metab Disord. 2017;18:167–182.
  • Freedman BI, Register TC. Effect of race and genetics on vitamin D metabolism, bone and vascular health. Net Rev Nephrol. 2012;8:459–466.
  • Pojednic RM, Ceglia L, Olsson K, et al. Effects of 1,25-dihydroxyvitamin D3 and vitamin D3 on the expression of the vitamin d receptor in human skeletal muscle cells. Calcif Tissue Int. 2015;96:256–263.
  • Hassan-Smith ZK, Jenkinson C, Smith DJ. 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 exert distinct effects on human skeletal muscle function and gene expression. PLoS One. 2017;12:e0170665.
  • Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc. 2007;55:234–239.
  • Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med. 2016;176:175–183.
  • Ceglia L, Niramitmahapanya S, Da Silva Morais M, et al. A randomized study on the effect of vitamin D supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab. 2013;98:E1927–E1935.
  • Schild A, Herter-Aeberli I, Fattinger K, et al. Oral vitamin D supplements increase serum 25-Hydroxyvitamin D in postmenopausal women and reduce bone calcium flux measured by 41Ca skeletal labeling. J Nutr. 2015;145:2333–2334.
  • Ekwaru JP, Zwicker JD, Holick MF, et al. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014;9(11):e111265.
  • Julian C, Lentjes MA, Huybrechts I, et al. Fracture risk in relation to serum 25-Hydroxyvitamin D and physical activity: results from the EPIC-Norfolk cohort study. PLoS One. 2016;11(10):e0164160.
  • Adegboye AR, Christensen LB, Holm-Pedersen P, et al. Intakes of calcium, vitamin D, and dairy servings and dental plaque in older Danish adults. Nutr J. 2013;12:61.
  • Gong A, Chen J, Wu J, et al. 25-Dihydroxyvitamin D deficiency accelerates alveolar bone loss independent of aging and extracellular calcium and phosphorus. J Periodontol. 2018;89(8):983-994.
  • Boucher BJ. Serum retinol levels and fracture risk. N Engl J Med. 2003;348:1927–1928. author reply 1927-8.
  • Holvik K, Ahmed LA, Forsmo SN, et al. No increase in risk of hip fracture at high serum retinol concentrations in community-dwelling older Norwegians: the Norwegian Epidemiologic Osteoporosis Studies. Am J Clin Nutr. 2015;102:1289–1296.
  • Cheng TY, Lacroix AZ, Beresford SA, et al. Vitamin D intake and lung cancer risk in the women’s health initiative. Am J Clin Nutr. 2013;98:1002–1011.
  • Uwitonze AM, Razzaque MS. Role of magnesium in vitamin D activation and function. J Am Osteopath Assoc. 2018;118:181–189.
  • Ben-Ishay N, Oknin H, Steinberg D, et al. Enrichment of milk with magnesium provides healthier and safer dairy products. J Biofilms Microbiomes. 2017;3:24.
  • Bartik L, Whitfield GK, Kaczmarska M, et al. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J Nutr Biochem. 2010;21:1153–1161.
  • Jorde R, Saleh F, Figenschau Y, et al. Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromsø study. Eur J Endocrinol. 2005;152:39–45.
  • Yen AM, Boucher BJ, Chiu SY. Longer duration and earlier age of onset of paternal betel chewing and smoking increase metabolic syndrome risk in human offspring, independently, in a community-based screening program in Taiwan. Circulation. 2016;134:392–404.
  • Yen AM, Chiu YH, Chen LS, et al. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. J Clin Nutr. 2006;83:1153–1160.
  • Ogunkolade WB1, Boucher BJ, Bustin SA, et al. Vitamin D metabolism in peripheral blood mononuclear cells is influenced by chewing “betel nut” (Areca catechu) and vitamin D status. J Clin Endocrinol Metab. 2006;91:2612–2617.
  • Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53–58.
  • Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842–856.
  • Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010;21:1151–1154.
  • Vaes AMM, Tieland M, de Regt MF, et al. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: a randomized controlled trial in older adults. Clin Nutr. 2018;37:808–814.
  • Veugelers PJ, Ekwaru JP. A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients. 2014;6:4472–4475.
  • Heaney R, Garland C, Baggerly C. Letter to Veugelers, P.J. and Ekwaru, J.P., A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients. 2014;6:4472–4475. Nutrients. 2015;7:1688–1690.
  • Hin H, Tomson J, Newman C, et al. Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care. Osteoporos Int. 2017;28:841–851.
  • Rolland Y, de Souto Barreto P, Abellan Van Kan G, et al. French group of geriatrics and nutrition. Vitamin D supplementation in older adults: searching for specific guidelines in nursing homes. J Nutr Health Aging. 2013;17:402–412.
  • Prentice A. Vitamin D deficiency: a global perspective. Nutr Rev. 2008;66(Suppl 2):S153–S164.
  • Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103:1033–1044.
  • Liu X, Baylin A, Levy PD. Vitamin D deficiency and insufficiency among US adults: prevalence, predictors and clinical implications. Br J Nutr. 2018;119:928–936.
  • Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144(Pt A):138–145.
  • Huang CH, Huang YA, Lai YC, et al. Prevalence and predictors of hypovitaminosis D among the elderly in subtropical region. PLoS One. 2017;12:e0181063.
  • Manios Y, Moschonis G, Lambrinou CP. A systematic review of vitamin D status in southern European countries. Eur J Nutr. 2018;57:2001–2036.
  • Annweiler C, Kabeshova A, Callens A. Self-administered vitamin D status predictor: older adults are able to use a self-questionnaire for evaluating their vitamin D status. PLoS One. 2017;12:e0186578.
  • Pourhassan M, Wirth R. Seasonal variation in vitamin D status among Frail Older Hospitalized Patients. J Frailty Aging. 2018;7:95–99.
  • Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R. Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int. 2013;24:1567–1577.
  • Newman MS, Brandon TR, Groves MN, et al. A liquid chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening. J Diabetes Sci Technol. 2009;3:156–162.
  • Jorde R, Sneve M, Hutchinson M, et al. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol. 2010;171:903–908.
  • Grant WB, Boucher BJ, Bhattoa HP, et al. Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol. 2018;177:266–269.
  • Sempos CT, Heijboer AC, Bikle DD, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the first international conference on controversies in vitamin D. Br J Clin Pharmacol. 2018. DOI:10.1111/bcp.13652 [Epub ahead of print].
  • Manson JE, Bassuk SS, Lee IM, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012;33:159–171.
  • Lappe JM, Heaney RP. Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinology. 2012;4:95–100.
  • Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Ckin Proc. 2013;88:720–755.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.